Arkolith/Insider Trading/BLPH/Form 4

Amin Naseem

DirectorBellerophon Therapeutics, Inc. (BLPH) · full profile →Form 4 · filed Jan 4, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2021Grant(A)39K—$0160K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 31, 2021Grant(A)9K$3.10$27K24K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-22-000186) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML